Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Schrama David |

** = Publikationen gelistet in SCI/SSCI/Pubmed

2021

Originalarbeit (Zeitschrift)

** Fan, K; Spassova, I; Gravemeyer, J; Ritter, C; Horny, K; Lange, A; Gambichler, T; Ødum, N; Schrama, D; Schadendorf, D; Ugurel, S; Becker, JC Merkel cell carcinoma-derived exosome-shuttle miR-375 induces fibroblast polarization by inhibition of RBPJ and p53.
Oncogene. 2021; 40(5):980-996 Doi: 10.1038/s41388-020-01576-6 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2020

Originalarbeit (Zeitschrift)

** Fan, K; Gravemeyer, J; Ritter, C; Rasheed, K; Gambichler, T; Moens, U; Shuda, M; Schrama, D; Becker, JC MCPyV Large T Antigen-Induced Atonal Homolog 1 Is a Lineage-Dependency Oncogene in Merkel Cell Carcinoma.
J Invest Dermatol. 2020; 140(1):56-65 Doi: 10.1016/j.jid.2019.06.135 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Fan, K; Zebisch, A; Horny, K; Schrama, D; Becker, JC Highly Expressed miR-375 is not an Intracellular Oncogene in Merkel Cell Polyomavirus-Associated Merkel Cell Carcinoma.
Cancers (Basel). 2020; 12(3): Doi: 10.3390/cancers12030529 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2018

Originalarbeit (Zeitschrift)

** Fan, K; Ritter, C; Nghiem, P; Blom, A; Verhaegen, ME; Dlugosz, A; Ødum, N; Woetmann, A; Tothill, RW; Hicks, RJ; Sand, M; Schrama, D; Schadendorf, D; Ugurel, S; Becker, JC Circulating Cell-Free miR-375 as Surrogate Marker of Tumor Burden in Merkel Cell Carcinoma.
Clin Cancer Res. 2018; 24(23):5873-5882 Doi: 10.1158/1078-0432.CCR-18-1184 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2017

Originalarbeit (Zeitschrift)

** Ofner, R; Ritter, C; Heidenreich, B; Kumar, R; Ugurel, S; Schrama, D; Becker, JC Distribution of TERT promoter mutations in primary and metastatic melanomas in Austrian patients.
J Cancer Res Clin Oncol. 2017; 143(4):613-617 Doi: 10.1007/s00432-016-2322-1 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Ofner, R; Ritter, C; Ugurel, S; Cerroni, L; Stiller, M; Bogenrieder, T; Solca, F; Schrama, D; Becker, JC Non-reproducible sequence artifacts in FFPE tissue: an experience report.
J Cancer Res Clin Oncol. 2017; 143(7):1199-1207 Doi: 10.1007/s00432-017-2399-1 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Ritter, C; Fan, K; Paschen, A; Reker Hardrup, S; Ferrone, S; Nghiem, P; Ugurel, S; Schrama, D; Becker, JC Epigenetic priming restores the HLA class-I antigen processing machinery expression in Merkel cell carcinoma.
Sci Rep. 2017; 7(1):2290-2290 Doi: 10.1038/s41598-017-02608-0 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2016

Originalarbeit (Zeitschrift)

** Ritter, C; Fan, K; Paulson, KG; Nghiem, P; Schrama, D; Becker, JC Reversal of epigenetic silencing of MHC class I chain-related protein A and B improves immune recognition of Merkel cell carcinoma.
Sci Rep. 2016; 6:21678-21678 Doi: 10.1038/srep21678 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Willmes, C; Kumar, R; Becker, JC; Fried, I; Rachakonda, PS; Poppe, LM; Hesbacher, S; Schadendorf, D; Sucker, A; Schrama, D; Ugurel, S SERPINB1 expression is predictive for sensitivity and outcome of cisplatin-based chemotherapy in melanoma.
Oncotarget. 2016; 7(9): 10117-10132. Doi: 10.18632/oncotarget.6956 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Zeitschrift)

** Lyngaa, R; Pedersen, NW; Linnemann, C; Schrama, D; Ibrani, D; Met, O; Straten, PT; Nghiem, P; Becker, JC; Hadrup, SR Using Merkel cell polyomavirus specific TCR gene therapy for treatment of Merkel cell carcinoma
EUR J IMMUNOL. .. 2016; 46: 128-128.-International Congress of Immunology (ICI); AUG 21-26, 2016; Melbourne, AUSTRALIA. [Poster]
Web of Science

 

2015

Originalarbeit (Zeitschrift)

** Houben, R; Angermeyer, S; Haferkamp, S; Aue, A; Goebeler, M; Schrama, D; Hesbacher, S Characterization of functional domains in the Merkel cell polyoma virus Large T antigen.
Int J Cancer. 2015; 136(5):E290-E300 Doi: 10.1002/ijc.29200 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Ritter, C; Fan, K; Houben, R; Schrama, D; Becker, JC Enhanced MHC class I molecule expression on Merkel cell carcinoma by HDAC inhibitors
EXP DERMATOL. . 2015; 24(3):E23-E24.-42nd Annual Meeting of the Arbeitsgemeinschaft-Dermatologische-Forschung (ADF); MAR 05-07, 2015; Ulm, GERMANY. [Oral Communication]
Web of Science

 

2014

Originalarbeit (Zeitschrift)

** Adam, C; Baeurle, A; Brodsky, JL; Wipf, P; Schrama, D; Becker, JC; Houben, R The HSP70 modulator MAL3-101 inhibits Merkel cell carcinoma.
PLoS One. 2014; 9(4):e92041-e92041 Doi: 10.1371/journal.pone.0092041 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Haugg, AM; Rennspiess, D; zur Hausen, A; Speel, EJ; Cathomas, G; Becker, JC; Schrama, D Fluorescence in situ hybridization and qPCR to detect Merkel cell polyomavirus physical status and load in Merkel cell carcinomas.
Int J Cancer. 2014; 135(12):2804-2815 Doi: 10.1002/ijc.28931 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Lyngaa, R; Pedersen, NW; Schrama, D; Thrue, CA; Ibrani, D; Met, O; Thor Straten, P; Nghiem, P; Becker, JC; Hadrup, SR T-cell responses to oncogenic merkel cell polyomavirus proteins distinguish patients with merkel cell carcinoma from healthy donors.
Clin Cancer Res. 2014; 20(7):1768-1778 Doi: 10.1158/1078-0432.CCR-13-2697 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Paulson, KG; Tegeder, A; Willmes, C; Iyer, JG; Afanasiev, OK; Schrama, D; Koba, S; Thibodeau, R; Nagase, K; Simonson, WT; Seo, A; Koelle, DM; Madeleine, M; Bhatia, S; Nakajima, H; Sano, S; Hardwick, JS; Disis, ML; Cleary, MA; Becker, JC; Nghiem, P Downregulation of MHC-I expression is prevalent but reversible in Merkel cell carcinoma.
Cancer Immunol Res. 2014; 2(11):1071-1079 Doi: 10.1158/2326-6066.CIR-14-0005 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Schrama, D; Groesser, L; Ugurel, S; Hafner, C; Pastrana, DV; Buck, CB; Cerroni, L; Theiler, A; Becker, JC Presence of human polyomavirus 6 in mutation-specific BRAF inhibitor-induced epithelial proliferations.
JAMA Dermatol. 2014; 150(11):1180-1186 Doi: 10.1001/jamadermatol.2014.1116 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Zeitschrift)

** Fan, K; Ritter, C; Theiler, A; Houben, R; Schrama, D; Becker, JC Ectopic expression and secretion of miR-375 in MCC: Impact on the tumor microenvironment
J DTSCH DERMATOL GES. . 2014; 12: 8-9. [Poster]
Web of Science

 

** Houben, R; Goebeler, M; Angermeyer, S; Haferkamp, S; Schrama, D; Hesbacher, S Characterization of functional domains in the Merkel cell polyoma virus Large T antigen
J DTSCH DERMATOL GES. . 2014; 12: 19-19. [Poster]
Web of Science

 

** Ofner, R; Kumar, R; Heidenreich, B; Schrama, D; Becker, JC TERT promoter mutations in melanoma
J DTSCH DERMATOL GES. . 2014; 12: 42-43. [Poster]
Web of Science

 

** Ritter, C; Schrama, D; Houben, R; Becker, JC Enhanced MHC class I molecule expression on Merkel cell carcinoma by HDAC inhibitors
J DTSCH DERMATOL GES. . 2014; 12: 8-8. [Poster]
Web of Science

 

** Schrama, D; Groesser, L; Haffner, C; Ugurel, S; Pastrana, D; Buck, C; Cerroni, L; Theiler, A; Becker, JC Presence of human polyomavirus 6 in mutation-specific BRAF inhibitor induced epithelial proliferations
J DTSCH DERMATOL GES. 2014; 12: 42-42.-Deutscher Hautkrebskongress und ADO-Jahrestagung; SEP 11-13 2014; Frankfurt am Main, GERMANY. [Poster]
Web of Science

 

** Theiler, A; Schrama, D; Becker, JC PARP-1 activation in Merkel cell carcinoma (MCC)
J DTSCH DERMATOL GES. . 2014; 12: 18-18. [Poster]
Web of Science

 

Kommentar

** Angermeyer, S; Hesbacher, S; Becker, JC; Schrama, D; Houben, R Response to Shuda et al.
J Invest Dermatol. 2014; 134(5):1481-1482 Doi: 10.1038/jid.2013.486 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2013

Originalarbeit (Zeitschrift)

** Angermeyer, S; Hesbacher, S; Becker, JC; Schrama, D; Houben, R Merkel cell polyomavirus-positive Merkel cell carcinoma cells do not require expression of the viral small T antigen.
J Invest Dermatol. 2013; 133(8):2059-2064 Doi: 10.1038/jid.2013.82 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Houben, R; Dreher, C; Angermeyer, S; Borst, A; Utikal, J; Haferkamp, S; Peitsch, WK; Schrama, D; Hesbacher, S Mechanisms of p53 restriction in Merkel cell carcinoma cells are independent of the Merkel cell polyoma virus T antigens.
J Invest Dermatol. 2013; 133(10):2453-2460 Doi: 10.1038/jid.2013.169 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Loader, DE; Feldmann, R; Baumgartner, M; Breier, F; Schrama, D; Becker, JC; Steiner, A Clinical remission of Merkel cell carcinoma after treatment with imatinib.
J Am Acad Dermatol. 2013; 69(4):e181-e183 Doi: 10.1016/j.jaad.2013.03.042 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Kurzbericht/Letter

** Richtig, E; Schrama, D; Ugurel, S; Fried, I; Niederkorn, A; Massone, C; Becker, JC BRAF mutation analysis of only one single metastatic lesion can restrict the treatment of melanoma - a case report.
Br J Dermatol. 2013; 168(2):428-430 Doi: 10.1111/j.1365-2133.2012.11121.x (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

** Schrama, D; Hesbacher, S; Becker, JC; Houben, R Survivin downregulation is not required for T antigen knockdown mediated cell growth inhibition in MCV infected merkel cell carcinoma cells.
Int J Cancer. 2013; 132(12):2980-2982 Doi: 10.1002/ijc.27962 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Übersichtsarbeit

** Becker, JC; Andersen, MH; Schrama, D; Thor Straten, P Immune-suppressive properties of the tumor microenvironment.
Cancer Immunol Immunother. 2013; 62(7):1137-1148 Doi: 10.1007/s00262-013-1434-6
Web of Science PubMed FullText FullText_MUG

 

Editorial

** Becker, JC; Schrama, D; The Dark Side of Cyclophosphamide: Cyclophosphamide-Mediated Ablation of Regulatory T Cells.
J INVEST DERMATOL. 2013; 133(6): 1462-1465. Doi: 10.1038/jid.2013.67 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Haferkamp, S; Houben, R; Dreher, C; Angermeyer, S; Borst, A; Utikal, J; Ludwig-Peitsch, WK; Schrama, D; Hesbacher, S; Mechanisms of p53 restriction in Merkel cell carcinoma cells are independent of the Merkel cell polyoma virus T antigens.
J DTSCH DERMATOL GES. . 2013; 11(9):945-945. [Poster]
Web of Science

 

** Ritter, C; Becker, JC; Schrama, D; Reversible epigenetic silencing of NKG2D ligands MICA and MICB in Merkel cell carcinoma.
EXP DERMATOL. 2013; 22(3):E42-E42.-40th Annual Meeting of the Association-of-Dermatological-Research; MAR 14-16, 2013; Dessau, GERMANY. [Oral Communication]
Web of Science

 

** Ritter, C; Schrama, D; Becker, JC; Reinduction of epigenetically silenced NKG2D ligands MICA and MICB in Merkel cell carcinoma.
J DTSCH DERMATOL GES. 2013; 11(9):907-907.-ADO-Tagung; September, 2013; Essen, D. [Oral Communication]
Web of Science

 

** Schrama, D; Ritter, C; Becker, J; PDGFR alpha and Merkel Cell Carcinoma: pS478P Polymorphism and PDGFR-Inhibitors.
J DTSCH DERMATOL GES. 2013; 11(9):945-946.-ADO-Tagung; September, 2013; Essen, D. [Oral Communication]
Web of Science

 

** Schrama, D; Ugurel, S; Schadendorf, D; Becker, JC; No association of STAT3 rs4796793 SNP with response to IFN alpha therapy in patients with metastatic melanoma.
EXP DERMATOL. 2013; 22(3):E22-E22.-40th Annual Meeting of the Association-of-Dermatological-Research; MAR 14-16, 2013; Dessau, GERMANY. [Poster]
Web of Science

 

** Theiler, A; Schrama, D; Becker, JC; Modulation of the Tumor Microenvironment by Microvesicles derived from the Merkel Cell Carcinoma (MCC).
J DTSCH DERMATOL GES. 2013; 11(9):959-960.-ADO-Tagung; Sept, 2013; Essen, D. [Oral Communication]
Web of Science

 

2012

Originalarbeit (Zeitschrift)

** Alb, M; Sie, C; Adam, C; Chen, S; Becker, JC; Schrama, D Cellular and cytokine-dependent immunosuppressive mechanisms of grm1-transgenic murine melanoma.
Cancer Immunol Immunother. 2012; 61(12):2239-2249 Doi: 10.1007/s00262-012-1290-9 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Becker, JC; Andersen, MH; Hofmeister-Muller, V; Wobser, M; Frey, L; Sandig, C; Walter, S; Singh-Jasuja, H; Kampgen, E; Opitz, A; Zapatka, M; Brocker, EB; Straten, PT; Schrama, D; Ugurel, S; Survivin-specific T-cell reactivity correlates with tumor response and patient survival: a phase-II peptide vaccination trial in metastatic melanoma.
Cancer Immunol Immunother. 2012; 61(11):2091-2103 Doi: 10.1007/s00262-012-1266-9 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Hafner, C; Houben, R; Baeurle, A; Ritter, C; Schrama, D; Landthaler, M; Becker, JC Activation of the PI3K/AKT pathway in Merkel cell carcinoma.
PLoS One. 2012; 7(2):e31255-e31255 Doi: 10.1371/journal.pone.0031255 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Houben, R; Adam, C; Baeurle, A; Hesbacher, S; Grimm, J; Angermeyer, S; Henzel, K; Hauser, S; Elling, R; Bröcker, EB; Gaubatz, S; Becker, JC; Schrama, D An intact retinoblastoma protein-binding site in Merkel cell polyomavirus large T antigen is required for promoting growth of Merkel cell carcinoma cells.
Int J Cancer. 2012; 130(4): 847-856. Doi: 10.1002/ijc.26076 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Vlahova, L; Doerflinger, Y; Houben, R; Becker, JC; Schrama, D; Weiss, C; Goebeler, M; Helmbold, P; Goerdt, S; Peitsch, WK P-cadherin expression in Merkel cell carcinomas is associated with prolonged recurrence-free survival.
Br J Dermatol. 2012; 166(5):1043-1052 Doi: 10.1111/j.1365-2133.2012.10853.x
Web of Science PubMed FullText FullText_MUG

 

** Willmes, C; Adam, C; Alb, M; Völkert, L; Houben, R; Becker, JC; Schrama, D Type I and II IFNs inhibit Merkel cell carcinoma via modulation of the Merkel cell polyomavirus T antigens.
Cancer Res. 2012; 72(8): 2120-2128. Doi: 10.1158/0008-5472.CAN-11-2651 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Kurzbericht/Letter

** Houben, R; Grimm, J; Willmes, C; Weinkam, R; Becker, JC; Schrama, D Merkel cell carcinoma and Merkel cell polyomavirus: evidence for hit-and-run oncogenesis.
J Invest Dermatol. 2012; 132(1): 254-256. Doi: 10.1038/jid.2011.260 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Schrama, D; Buck, CB; Houben, R; Becker, JC No evidence for association of HPyV6 or HPyV7 with different skin cancers.
J Invest Dermatol. 2012; 132(1): 239-241. Doi: 10.1038/jid.2011.261 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Übersichtsarbeit

** Schrama, D; Ugurel, S; Becker, JC Merkel cell carcinoma: recent insights and new treatment options.
Curr Opin Oncol. 2012; 24(2): 141-149. Doi: 10.1097/CCO.0b013e32834fc9fe
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Haugg, A; Rennspiess, D; zur Hausen, A; Speel, EJM; Cathomas, G; Becker, J; Schrama, D Detection of Merkel Cell Polyomavirus in Formalin-Fixed and Paraffin-Embedded Tissues by Fluorescence In Situ Hybridisation and Its Correlation with qPCR
LAB INVEST. 2012; 92: 122A-122A.-101st Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP); MAR 17-23, 2012; Vancouver, CANADA. [Poster]
Web of Science

 

** Haugg, A; Rennspiess, D; zur Hausen, A; Speel, EJM; Cathomas, J; Becker, J; Schrama, D Detection of Merkel Cell Polyomavirus in Formalin-Fixed and Paraffin-Embedded Tissues by Fluorescence In Situ Hybridisation and Its Correlation with qPCR
MODERN PATHOL. 2012; 25: 122A-122A.-101st Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology; MAR 17-23, 2012; Vancouver, CANADA. [Poster]
Web of Science

 

** Speel, EM; Haugg, A; Rennspiess, D; zur Hausen, A; Cathomas, G; Becker, J; Schrama, D; Comprehensive Assessment of Merkel Cell Polyomavirus in Merkel Cell Carcinomas: Fluorescence in situ Hybridization Versus qPCR?.
J MOL DIAGN. 2012; 14(6):677-677.-Annual Meeting of the Association-for-Molecular-Pathology; OCT 25-27, 2012; Long Beach, CA. [Poster]
Web of Science

 

** Vlahova, L; Dorflinger, Y; Houben, R; Brandner, JM; Becker, JC; Schrama, D; Goebeler, M; Helmbold, P; Weiss, C; Goerdt, S; Peitsch, WK P-cadherin expression in primary Merkel cell carcinomas is associated with prolonged recurrence-free survival
EXP DERMATOL. 2012; 21(3):e43-e43.-39th Annual Meeting of the Arbeitsgemeinschaft-Dermatologische-Forschung (ADF); MAR 01-03, 2012; Marburg, GERMANY. [Oral Communication]
Web of Science

 

Kommentar

** Becker, JC; Schrama, D Control of central and peripheral tolerance to melanocyte differentiation antigens by GILT.
J INVEST DERMATOL. 2012; 132(1): 15-17. Doi: 10.1038/jid.2011.361 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2011

Originalarbeit (Zeitschrift)

** Houben, R; Hesbacher, S; Schmid, CP; Kauczok, CS; Flohr, U; Haferkamp, S; Müller, CS; Schrama, D; Wischhusen, J; Becker, JC High-level expression of wild-type p53 in melanoma cells is frequently associated with inactivity in p53 reporter gene assays.
PLoS One. 2011; 6(7):e22096-e22096 Doi: 10.1371/journal.pone.0022096 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Karki, P; Li, X; Schrama, D; Fliegel, L B-Raf Associates with and Activates the NHE1 Isoform of the Na+/H+ Exchanger.
J Biol Chem. 2011; 286(15): 13096-13105. Doi: 10.1074/jbc.M110.165134 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Paulson, KG; Iyer, JG; Tegeder, AR; Thibodeau, R; Schelter, J; Koba, S; Schrama, D; Simonson, WT; Lemos, BD; Byrd, DR; Koelle, DM; Galloway, DA; Leonard, JH; Madeleine, MM; Argenyi, ZB; Disis, ML; Becker, JC; Cleary, MA; Nghiem, P Transcriptome-Wide Studies of Merkel Cell Carcinoma and Validation of Intratumoral CD8+ Lymphocyte Invasion As an Independent Predictor of Survival
J CLIN ONCOL. 2011; 29(12): 1539-1546. Doi: 10.1200/JCO.2010.30.6308 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG Google Scholar

 

** Schrama, D; Becker, JC Merkel cell carcinoma--pathogenesis, clinical aspects and treatment.
J Eur Acad Dermatol Venereol. 2011; 25(10):1121-1129 Doi: 10.1111/j.1468-3083.2011.04032.x
Web of Science PubMed FullText FullText_MUG

 

** Schrama, D; Peitsch, WK; Zapatka, M; Kneitz, H; Houben, R; Eib, S; Haferkamp, S; Moore, PS; Shuda, M; Thompson, JF; Trefzer, U; Pföhler, C; Scolyer, RA; Becker, JC Merkel cell polyomavirus status is not associated with clinical course of Merkel cell carcinoma.
J Invest Dermatol. 2011; 131(8):1631-1638 Doi: 10.1038/jid.2011.115 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Schrama, D; Scherer, D; Schneider, M; Zapatka, M; Bröcker, EB; Schadendorf, D; Ugurel, S; Kumar, R; Becker, JC ERCC5 p.Asp1104His and ERCC2 p.Lys751Gln Polymorphisms Are Independent Prognostic Factors for the Clinical Course of Melanoma.
J Invest Dermatol. 2011; 131(6):1280-1290 Doi: 10.1038/jid.2011.35 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Werling, AM; Doerflinger, Y; Brandner, JM; Fuchs, F; Becker, JC; Schrama, D; Kurzen, H; Goerdt, S; Peitsch, WK Homo- and heterotypic cell-cell contacts in Merkel cells and Merkel cell carcinomas: heterogeneity and indications for cadherin switching.
Histopathology. 2011; 58(2):286-303 Doi: 10.1111/j.1365-2559.2011.03748.x
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Adam, C; Houben, R; Baeurle, A; Brodsky, JL; Wipf, P; Schrama, D; Becker, JC The HSP70 inhibitor MAL3-101 affects merkel cell carcinoma in vitro and in vivo
EXP DERMATOL. 2011; 20(2): P202 [Oral Communication]
Web of Science

 

** Paulson, K; Tegeder, A; Willmes, C; Iyer, J; Schrama, D; Koelle, D; Cleary, M; Bhatia, S; Becker, J; Nghiem, P Reversal of local immune evasion mechanisms and regression of human Merkel cell carcinoma by intralesional injection of interferon-beta
J INVEST DERMATOL. 2011; 131: 547- [Poster]
Web of Science

 

** Schmid, C; Houben, R; Hesbacher, S; Kauczok, CS; Flohr, U; Haferkamp, S; Muller, C; Schrama, D; Wischhusen, J; Becker, J High-level expression of wild-type p53 in melanoma cells is frequently associated with inactivity in p53 reporter gene assays
J DTSCH DERMATOL GES. 2011; 9(9):795-796. [Poster]
Web of Science

 

** Willmes, C; Adam, C; Alb, M; Volkert, L; Houben, R; Becker, JC; Schrama, D Interferons affect cellular viability and class I major histocompatibility complex expression in both MCV positive and negative merkel cell carcinoma cell lines
EXP DERMATOL. 2011; 20(2): P212 [Poster]
Web of Science

 

Kommentar

** Becker, JC; Schrama, D Breaking immunological tolerance to melanocyte differentiation antigens by hypopigmenting agents: a new means for melanoma immunotherapy?
J Invest Dermatol. 2011; 131(6):1185-1187 Doi: 10.1038/jid.2011.94 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2010

Originalarbeit (Zeitschrift)

** Houben, R; Shuda, M; Weinkam, R; Schrama, D; Feng, H; Chang, Y; Moore, PS; Becker, JC Merkel cell polyomavirus-infected Merkel cell carcinoma cells require expression of viral T antigens.
J Virol. 2010; 84(14):7064-7072 Doi: 10.1128/JVI.02400-09 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG Google Scholar

 

** Paulson, KG; Carter, JJ; Johnson, LG; Cahill, KW; Iyer, JG; Schrama, D; Becker, JC; Madeleine, MM; Nghiem, P; Galloway, DA Antibodies to merkel cell polyomavirus T antigen oncoproteins reflect tumor burden in merkel cell carcinoma patients.
Cancer Res. 2010; 70(21): 8388-8397. Doi: 10.1158/0008-5472.CAN-10-2128 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG Google Scholar

 

** Scurr, LL; Pupo, GM; Becker, TM; Lai, K; Schrama, D; Haferkamp, S; Irvine, M; Scolyer, RA; Mann, GJ; Becker, JC; Kefford, RF; Rizos, H IGFBP7 is not required for B-RAF-induced melanocyte senescence.
Cell. 2010; 141(4):717-727 Doi: 10.1016/j.cell.2010.04.021 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Kurzbericht/Letter

** Houben, R; Schrama, D; Alb, M; Pfohler, C; Trefzer, U; Ugurel, S; Becker, JC Comparable expression and phosphorylation of the retinoblastoma protein in Merkel cell polyoma virus-positive and negative Merkel cell carcinoma.
Int J Cancer. 2010; 126(3):796-798 Doi: 10.1002/ijc.24790 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Schrama, D; Kneitz, H; Willmes, C; Adam, C; Houben, R; Becker, JC Lack of correlation between IGFBP7 expression and BRAF mutational status in melanoma.
J Invest Dermatol. 2010; 130(3):897-898 Doi: 10.1038/jid.2009.304 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Schrama, D; Thiemann, A; Houben, R; Kahler, KC; Becker, JC; Hauschild, A Distinction of 2 different primary Merkel cell carcinomas in 1 patient by Merkel cell polyomavirus genome analysis.
Arch Dermatol. 2010; 146(6):687-689 Doi: 10.1001/archdermatol.2010.121 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Übersichtsarbeit

** Becker, JC; Houben, R; Schrama, D; Voigt, H; Ugurel, S; Reisfeld, RA Mouse models for melanoma: a personal perspective.
Exp Dermatol. 2010; 19(2): 157-164. Doi: 10.1111/j.1600-0625.2009.00986.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2009

Originalarbeit (Zeitschrift)

** Groneck, L; Schrama, D; Fabri, M; Stephen, TL; Harms, F; Meemboor, S; Hafke, H; Bessler, M; Becker, JC; Kalka-Moll, WM Oligoclonal CD4+ T cells promote host memory immune responses to Zwitterionic polysaccharide of Streptococcus pneumoniae.
Infect Immun. 2009; 77(9):3705-3712 Doi: 10.1128/IAI.01492-08 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG Google Scholar

 

** Hofmeister-Mueller, V; Vetter-Kauczok, CS; Ullrich, R; Meder, K; Lukanidin, E; Broecker, EB; Straten, PT; Andersen, MH; Schrama, D; Becker, JC Immunogenicity of HLA-A1-restricted peptides derived from S100A4 (metastasin 1) in melanoma patients.
Cancer Immunol Immunother. 2009; 58(8):1265-1273 Doi: 10.1007/s00262-008-0640-0 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Houben, R; Voigt, H; Noelke, C; Hofmeister, V; Becker, JC; Schrama, D MAPK-independent impairment of T-cell responses by the multikinase inhibitor sorafenib.
Mol Cancer Ther. 2009; 8(2):433-440 Doi: 10.1158/1535-7163.MCT-08-1051 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Sorensen, RB; Faurschou, M; Troelsen, L; Schrama, D; Jacobsen, S; Becker, JC; Straten, PT; Andersen, MH Melanoma inhibitor of apoptosis protein (ML-IAP) specific cytotoxic T lymphocytes cross-react with an epitope from the auto-antigen SS56.
J Invest Dermatol. 2009; 129(8):1992-1999 Doi: 10.1038/jid.2009.10 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Voigt, H; Vetter-Kauczok, CS; Schrama, D; Hofmann, UB; Becker, JC; Houben, R CD147 impacts angiogenesis and metastasis formation.
Cancer Invest. 2009; 27(3):329-333 Doi: 10.1080/07357900802392675
Web of Science PubMed FullText FullText_MUG

 

Kurzbericht/Letter

** Becker, JC; Houben, R; Ugurel, S; Trefzer, U; Pfohler, C; Schrama, D MC polyomavirus is frequently present in Merkel cell carcinoma of European patients.
J Invest Dermatol. 2009; 129(1):248-250 Doi: 10.1038/jid.2008.198 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Übersichtsarbeit

** Becker, JC; Schrama, D; Houben, R Merkel cell carcinoma.
Cell Mol Life Sci. 2009; 66(1):1-8 Doi: 10.1007/s00018-008-8483-6
Web of Science PubMed FullText FullText_MUG

 

** Houben, R; Schrama, D; Becker, JC Molecular pathogenesis of Merkel cell carcinoma.
Exp Dermatol. 2009; 18(3):193-198 Doi: 10.1111/j.1600-0625.2009.00853.x
Web of Science PubMed FullText FullText_MUG

 

2008

Originalarbeit (Zeitschrift)

** Houben, R; Wischhusen, J; Menaa, F; Synwoldt, P; Schrama, D; Brocker, EB; Becker, JC Melanoma stem cells: targets for successful Therapy?
J DTSCH DERMATOL GES. 2008; 6(7): 541-547. Doi: 10.1111/j.1610-0387.2008.06786.x
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Ochsenreither, S; Fusi, A; Busse, A; Nagorsen, D; Schrama, D; Becker, J; Thiel, E; Keilholz, U Relative quantification of TCR Vbeta-chain families by real time PCR for identification of clonal T-cell populations.
J Transl Med. 2008; 6(1):34-34 Doi: 10.1186/1479-5876-6-34 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Rappl, G; Schrama, D; Hombach, A; Meuer, EK; Schmidt, A; Becker, JC; Abken, H CD7(-) T cells are late memory cells generated from CD7(+) T cells
REJUV RES. 2008; 11(3): 543-556. Doi: 10.1089/rej.2007.0612
Web of Science PubMed FullText FullText_MUG

 

** Schrama, D; Keller, G; Houben, R; Ziegler, CG; Vetter-Kauczok, CS; Ugurel, S; Becker, JC BRAFV600E mutations in malignant melanoma are associated with increased expressions of BAALC.
J Carcinog. 2008; 7(1):1-1 Doi: 10.1186/1477-3163-7-1 [OPEN ACCESS]
PubMed PUBMED Central FullText FullText_MUG Google Scholar

 

** Schrama, D; Voigt, H; Eggert, AO; Xiang, R; Zhou, H; Schumacher, TNM; Andersen, MH; Straten, PT; Reisfeld, RA; Becker, JC Immunological tumor destruction in a murine melanoma model by targeted LT alpha independent of secondary lymphoid tissue
CANCER IMMUNOL IMMUNOTHER. 2008; 57(1): 85-95. Doi: 10.1007/s00262-007-0352-x
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Ugurel, S; Schrama, D; Keller, G; Schadendorf, D; Brocker, EB; Houben, R; Zapatka, M; Fink, W; Kaufman, HL; Becker, JC Impact of the CCR5 gene polymorphism on the survival of metastatic melanoma patients receiving immunotherapy.
Cancer Immunol Immunother. 2008; 57(5):685-691 Doi: 10.1007/s00262-007-0407-z
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Übersichtsarbeit

** Andersen, MH; Sorensen, RB; Schrama, D; Svane, IM; Becker, JC; Straten, PT Cancer treatment: the combination of vaccination with other therapies.
CANCER IMMUNOL IMMUNOTHER. 2008; 57(11): 1735-1743. Doi: 10.1007/s00262-008-0480-y [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG Google Scholar

 

** Becker, JC; Ugurel, S; Schrama, D Strategies to optimize the use of targeted agents for tumor therapy.
J Dtsch Dermatol Ges. 2008; 6(4):281-285 Doi: 10.1111/j.1610-0387.2008.06496.x
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Hofmeister, V; Schrama, D; Becker, JC Anti-cancer therapies targeting the tumor stroma
CANCER IMMUNOL IMMUNOTHER. 2008; 57(1): 1-17. Doi: 10.1007/s00262-007-0365-5
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Schrama, D; Hauschild, A; Becker, JC Immunmodulatory antibodies in the treatment of skin cancer
Hautarzt. 2008; 59(10):806-813 Doi: 10.1007/s00105-008-1539-6
Web of Science PubMed FullText FullText_MUG

 

2007

Originalarbeit (Zeitschrift)

** Houben, R; Ortmann, S; Schrama, D; Herold, MJ; Berberich, I; Reichardt, HM; Becker, JC Activation of the MAP kinase pathway induces apoptosis in the Merkel cell carcinoma cell line UISO.
J Invest Dermatol. 2007; 127(9):2116-2122 Doi: 10.1038/sj.jid.5700857 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Stephen, TL; Fabri, M; Groneck, L; Rohn, TA; Hafke, H; Robinson, N; Rietdorf, J; Schrama, D; Becker, JC; Plum, G; Kronke, M; Kropshofer, H; Kalka-Moll, WM Transport of Streptococcus pneumoniae capsular polysaccharide in MHC class II tubules
PLOS PATHOG. 2007; 3(3): Doi: 10.1371/journal.ppat.0030032 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG Google Scholar

 

** Ugurel, S; Houben, R; Schrama, D; Voigt, H; Zapatka, M; Schadendorf, D; Brocker, EB; Becker, JC Microphthalmia-associated transcription factor gene amplification in metastatic melanoma is a prognostic marker for patient survival, but not a predictive marker for chemosensitivity and chemotherapy response.
Clin Cancer Res. 2007; 13(21):6344-6350 Doi: 10.1158/1078-0432.CCR-06-2682 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Voigt, H; Houben, R; Schrama, D; Hofmann, UB; Vetter-Kauczok, CS; Becker, JC Matrix metalloproteinase induction in the tumor stroma does not depend on CD147 expression in murine B16 melanoma.
Tumour Biol. 2007; 28(4):229-237 Doi: 10.1159/000107418
Web of Science PubMed FullText FullText_MUG

 

** Wobser, M; Voigt, H; Houben, R; Eggert, AO; Freiwald, M; Kaemmerer, U; Kaempgen, E; Schrama, D; Becker, JC Dendritic cell based antitumor vaccination: impact of functional indoleamine 2,3-dioxygenase expression.
Cancer Immunol Immunother. 2007; 56(7):1017-1024 Doi: 10.1007/s00262-006-0256-1
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Kurzbericht/Letter

** Otto, K; Starz, H; Becker, JC; Schrama, D Overexpression of matrix metalloproteinases, chemokines, and chemokine receptors relevant for metastasis in experimental models not an indication of lymph node metastases in human melanoma.
Arch Dermatol. 2007; 143(7):947-948 Doi: 10.1001/archderm.143.7.947 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2006

Originalarbeit (Zeitschrift)

** Becker, JC; Ugurel, S; Bröcker, EB; Schrama, D; Houben, R New therapeutic approaches for solid tumors: histone deacetylase, methyltransferase and proteasome inhibitors.
J Dtsch Dermatol Ges. 2006; 4(2):108-113 Doi: 10.1111/j.1610-0387.2006.05920.x
PubMed FullText FullText_MUG Google Scholar

 

** Houben, R; Michel, B; Vetter-Kauczok, CS; Pfohler, C; Laetsch, B; Wolter, MD; Leonard, JH; Trefzer, U; Ugurel, S; Schrama, D; Becker, JC Absence of classical MAP kinase pathway signalling in Merkel cell carcinoma.
J Invest Dermatol. 2006; 126(5):1135-1142 Doi: 10.1038/sj.jid.5700170 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Schrama, D; Terheyden, P; Otto, K; Kammerer, U; Brocker, EB; Luhder, F; Cosman, D; Andersen, MH; Becker, JC Expression of the NKG2D ligand UL16 binding protein-1 (ULBP-1) on dendritic cells.
Eur J Immunol. 2006; 36(1):65-72 Doi: 10.1002/eji.200535115
Web of Science PubMed FullText FullText_MUG

 

** Schrama, D; Voigt, H; Eggert, AO; Xiang, R; Reisfeld, RA; Becker, JC Therapeutic efficacy of tumor-targeted IL2 in LTalpha(-/-) mice depends on conditioned T cells.
Cancer Immunol Immunother. 2006; 55(7):861-866 Doi: 10.1007/s00262-005-0076-8
Web of Science PubMed FullText FullText_MUG

 

** Straten, PT; Dahl, C; Schrama, D; Pedersen, LO; Andersen, MH; Seremet, T; Brocker, EB; Guldberg, P; Becker, JC Identification of identical TCRs in primary melanoma lesions and tumor free corresponding sentinel lymph nodes.
Cancer Immunol Immunother. 2006; 55(5):495-502 Doi: 10.1007/s00262-005-0023-8
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Voigt, H; Schrama, D; Eggert, AO; Vetter, CS; Muller-Blech, K; Reichardt, HM; Andersen, MH; Becker, JC; Luhder, F CD28-mediated costimulation impacts on the differentiation of DC vaccination-induced T cell responses.
Clin Exp Immunol. 2006; 143(1):93-102 Doi: 10.1111/j.1365-2249.2005.02972.x [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Wobser, M; Siedel, C; Schrama, D; Brocker, EB; Becker, JC; Vetter-Kauczok, CS Expression pattern of the lymphatic and vascular markers VEGFR-3 and CD31 does not predict regional lymph node metastasis in cutaneous melanoma.
Arch Dermatol Res. 2006; 297(8):352-357 Doi: 10.1007/s00403-005-0633-1
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Übersichtsarbeit

** Andersen, MH; Schrama, D; Straten, PT; Becker, JC Cytotoxic T cells.
J Invest Dermatol. 2006; 126(1):32-41 Doi: 10.1038/sj.jid.5700001 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Becker, JC; Kirkwood, JM; Agarwala, SS; Dummer, R; Schrama, D; Hauschild, A Molecularly targeted therapy for melanoma: current reality and future options.
Cancer. 2006; 107(10):2317-2327 Doi: 10.1002/cncr.22273 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Hofmeister, V; Vetter, C; Schrama, D; Brocker, EB; Becker, JC Tumor stroma-associated antigens for anti-cancer immunotherapy.
Cancer Immunol Immunother. 2006; 55(5):481-494 Doi: 10.1007/s00262-005-0070-1
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Klemke, CD; Goerdt, S; Schrama, D; Becker, JC New insights into the molecular biology and targeted therapy of cutaneous T-cell lymphomas.
J Dtsch Dermatol Ges. 2006; 4(5):395-406 Doi: 10.1111/j.1610-0387.2006.05982.x
PubMed FullText FullText_MUG

 

** Schrama, D; Reisfeld, RA; Becker, JC Antibody targeted drugs as cancer therapeutics.
Nat Rev Drug Discov. 2006; 5(2):147-159 Doi: 10.1038/nrd1957
Web of Science PubMed FullText FullText_MUG

 

2005

Originalarbeit (Zeitschrift)

** Vetter, CS; Muller-Blech, K; Schrama, D; Brocker, EB; Becker, JC Cytoplasmic and nuclear expression of survivin in melanocytic skin lesions.
Arch Dermatol Res. 2005; 297(1):26-30 Doi: 10.1007/s00403-005-0572-x
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Übersichtsarbeit

** Becker, JC; Schrama, D; Bröcker, EB; Houben, R Kinase inhibitors for the therapy of malignant melanoma
J Dtsch Dermatol Ges. 2005; 3(10):762-767 Doi: 10.1111/j.1610-0387.2005.05016.x
PubMed FullText FullText_MUG

 

2004

Originalarbeit (Zeitschrift)

** Berger, TG; Haendle, I; Schrama, D; Luftl, M; Bauer, N; Pedersen, LO; Schuler-Thurner, B; Hohenberger, W; Straten, PT; Schuler, G; Becker, JC Circulation and homing of melanoma-reactive T cells to both cutaneous and visceral metastases after vaccination with monocyte-derived dendritic cells
INT J CANCER. 2004; 111(2): 229-237. Doi: 10.1002/ijc.20238 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

** Eggert, AO; Andersen, MH; Voigt, H; Schrama, D; Kampgen, E; Straten, PT; Becker, JC Characterization of mouse MAGE-derived H-2K(b)-restricted CTL epitopes
EUR J IMMUNOL. 2004; 34(11): 3285-3290. Doi: 10.1002/eji.200324618
Web of Science PubMed FullText FullText_MUG

 

** Schrama, D; Rong, XA; Eggert, AO; Andersen, MH; Pedersen, LO; Kampgen, E; Schumacher, TN; Reisfeld, RR; Becker, JC Shift from systemic to site-specific memory by tumor-targeted IL-2
J IMMUNOL. 2004; 172(10): 5843-5850. Doi: 10.4049/jimmunol.172.10.5843 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Thor Straten, P; Schrama, D; Andersen, MH; Becker, JC T-cell clonotypes in cancer.
J Transl Med. 2004; 2(1):11-11 Doi: 10.1186/1479-5876-2-11 [OPEN ACCESS]
PubMed PUBMED Central FullText FullText_MUG

 

2003

Originalarbeit (Zeitschrift)

** Schrama, D; Eggert, AAO; Brocker, EB; Pedersen, LO; Straten, PT; Becker, JC Immunological consequences of the sentinel lymph-node biopsy - lessons from a melanoma patient
LANCET ONCOL. 2003; 4(7): 446-447. Doi: 10.1016/S1470-2045(03)01143-4 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Terheyden, P; Schrama, D; Pedersen, LO; Andersen, MH; Kampgen, E; Straten, PT; Becker, JC Longitudinal analysis of MART-1/HLA-A2-reactive T cells over the course of melanoma progression
SCAND J IMMUNOL. 2003; 58(5): 566-571. Doi: 10.1046/j.1365-3083.2003.01324.x
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Berger, TG; Haendle, I; Schrama, D; Lueftl, M; Oestergaard-Pedersen, L; Schuler-Thurner, B; Straten, PT; Schuler, G; Becker, JC Circulation and homing of melanoma-reactive T cell clones to both cutaneous and visceral metastases following DC-vaccination
J INVEST DERMATOL. 2003; 121(5): 1251-1251.
Web of Science

 

2002

Originalarbeit (Zeitschrift)

** Nanda, I; Schrama, D; Feichtinger, W; Haaf, T; Schartl, M; Schmid, M Distribution of telomeric (TTAGGG)(n) sequences in avian chromosomes.
Chromosoma. 2002; 111(4):215-227 Doi: 10.1007/s00412-002-0206-4
Web of Science PubMed FullText FullText_MUG

 

** Schrama, D; Fuchs, E; Brocker, EB; Straten, PT; Becker, JC Identical T-cell receptor transcripts in multiple melanoma metastases.
Cancer Res. 2002; 62(20):5664-5667 [OPEN ACCESS]
Web of Science PubMed FullText

 

** Schrama, D; Pedersen, LO; Keikavoussi, P; Andersen, MH; Straten, PT; Brocker, EB; Kampgen, E; Becker, JC Aggregation of antigen-specific T cells at the inoculation site of mature dendritic cells.
J Invest Dermatol. 2002; 119(6):1443-1448 Doi: 10.1046/j.1523-1747.2002.19604.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Schrama, D; Straten, P; Bröcker, EB; Reisfeld, RA; Becker, JC Cytokine fusion protein treatment.
Recent Results Cancer Res. 2002; 160(20):185-194 Doi: 10.1007/978-3-642-59410-6_22
PubMed FullText FullText_MUG

 

2001

Originalarbeit (Zeitschrift)

** Schrama, D; Andersen, MH; Terheyden, P; Schroder, L; Pedersen, LO; Straten, PT; Becker, JC Oligoclonal T-cell receptor usage of melanocyte differentiation antigen-reactive T cells in stage IV melanoma patients
CANCER RES. 2001; 61(2): 493-496. [OPEN ACCESS]
Web of Science PubMed FullText

 

** Schrama, D; Straten, PT; Fischer, WH; McLellan, AD; Brocker, EB; Reisfeld, RA; Becker, JC Targeting of lymphotoxin-alpha to the tumor elicits an efficient immune response associated with induction of peripheral lymphoid-like tissue
IMMUNITY. 2001; 14(2): 111-121. Doi: 10.1016/S1074-7613(01)00094-2 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Straten, PT; Guldberg, P; Schrama, D; Andersen, MH; Moerch, U; Seremet, T; Siedel, C; Reisfeld, RA; Becker, JC In situ cytokine therapy: redistribution of clonally expanded T cells
EUR J IMMUNOL. 2001; 31(1): 250-258. Doi: 10.1002/1521-4141(200101)31:1<250::AID-IMMU250>3.0.CO;2-8
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2000

Originalarbeit (Zeitschrift)

** Becker, JC; Vetter, CS; Schrama, D; Brocker, EB; Straten, PT Differential expression of CD28 and CD94/NKG2 on T cells with identical TCR beta variable regions in primary melanoma and sentinel lymph node
EUR J IMMUNOL. 2000; 30(12): 3699-3706. Doi: 10.1002/1521-4141(200012)30:12<3699::AID-IMMU3699>3.0.CO;2-2
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Moerch, U; Schrama, D; Guldberg, P; Seremet, T; Zeuthen, J; Becker, JC; Straten, PT Comparative delineation of T cell clonotypes in coexisting syngeneic B16 melanoma
CANCER IMMUNOL IMMUNOTHER. 2000; 49(8): 426-432. Doi: 10.1007/s002620000136
Web of Science PubMed FullText FullText_MUG Google Scholar

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum